메디에이지

Market position

Mediage positions itself as a digital healthcare data aggregator connecting health data across services, and states its biological-age index is validated in international SCI journals and through joint research with Korea's National Health Insurance Service. It reports partnerships with university and general hospitals and screening centres in Korea, and targets the domestic health check-up market, which it estimated at over KRW 8 trillion with a focus on corporate check-ups [0][1][3].

The company frames its differentiation around converting clinical check-up data into intuitive age-based indicators validated by SCI-journal publications and joint public-insurer research, a large accumulated clinical dataset used to fit the models, a patent portfolio covering several biological-age measurement systems, and a dual big-data platform combining its own data with hospital biobank data [0][1][2].

Technology

The system converts comprehensive health check-up clinical data into age-scaled indicators. According to company materials the models were built on over 2 million real clinical records with a reported R2 of 0.82, and earlier materials cite 1 million Korean clinical data points. Products span medical, metabolic, obesity/body-type, fitness and endocrine biological age, telomere measurement (Telo Age), gene analysis (My Gen Plan), and AI-based coaching that fuses lifelog data with check-up data (아임헬스). Listed patents include No. 10-0750662 (ECG-based biometric identification), 10-1398986 (medical biological age measurement system and terminal), 10-1469863 (obesity biological age), 10-1469864 (metabolic syndrome biological age) and 10-1177921 (organ biological age measurement system) [0][1][3].

Go-to-market

Distribution runs through affiliations with hospitals and health screening centres that deliver biological-age reports to check-up recipients, platform partnerships with large technology companies (Samsung Electronics' Samsung Health platform; an NDA with Daum Kakao), public-sector projects with the National Health Insurance Service and the Korea Health Industry Development Institute, public procurement listing, and overseas distributor and hospital agreements in China [0][3].

University and general hospitals and health screening centres, corporate employers procuring employee health check-ups and health management, health functional food and insurance sales channels, third-party digital health and diet services consuming the biological-age API, and individual health check-up recipients [0][1].

Geography

Headquartered in Seongnam, Gyeonggi Province, South Korea (earlier at Daewangpangyo-ro in Bundang-gu, later listed at 42 Changeop-ro, Sujeong-gu). Business development has targeted China, Japan and other Asian markets, with a Chinese distributor agreement, an MOU with a Chinese hospital and a system supply contract with Chinese company CIJI [0][1].

History

The company was established on 25 May 2011 with Kim Kang-hyung as CEO. It obtained venture business certification in March 2013, ISO 9001:2008 and ISO 14001:2004 certification in April 2013, and set up a corporate research institute in December 2013 alongside KDB IP financing based on patent valuation. In May 2014 it reached 170 contracted hospitals two years after launch, signed an SME agency startup growth project in June 2014, an NDA/MOU with KTH on mobile healthcare in October 2014, and was designated a Public Procurement Service excellent product in December 2014. In 2015 it launched a telomere age product, signed a Chinese distributor agreement and registered health functional food import sales, concluded an NDA with Daum Kakao, and signed an MOU with a Chinese hospital. In 2016 it signed a system construction and sales contract with Chinese firm CIJI, had its startup growth project judged successful, conducted personalised integrated health management programme research with the National Health Insurance Service, and signed an anti-ageing index development contract with the Korea Health Industry Development Institute. In April 2017 it announced a mobile healthcare service contract with Samsung Electronics [0][3].